Targeting interleukin-1 in the treatment of rheumatoid arthritis
- PMID: 11920390
- DOI: 10.1002/art.10168
Targeting interleukin-1 in the treatment of rheumatoid arthritis
Erratum in
- Arthritis Rheum 2002 Jun;46(6):1690
Comment on
-
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.Arthritis Rheum. 2002 Mar;46(3):614-24. doi: 10.1002/art.10141. Arthritis Rheum. 2002. PMID: 11920396 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical